Home | Contact Us 

Online Catalog

View our online catalog.
For further information or for a quotation, call 1-510-475-0650 or email us at

How Can We Help You?
Click here to contact us!


Sepragen in the News

January 2019: Sepragen Successfully Completes Research Using a National Science Foundation Grant, to Advance Stem Cell Bioreactors

May 2015: Sepragen delivers Chromatography System with integrated Buffer Dilution Capabilities

January 2015: Sepragen Welcomes Bio-reach as Distributor for the China Market

October 2014: Sepragen Receives Patent for Novel Wicking Bioreactor

July 2013: Sepragen wins Phase 1 STTR award from National Science Foundation for using its Express bioreactor technology to develop a low cost process for recombinant Heparin

March 2013: Sepragen Delivers Radial Flow Columns for Commercial production of Plasma Proteins

February 2013: Sepragen signs agreement with Delta Services to distribute its products in Egypt and neighboring countries

October 2012: Sepragen Announces the Launch of Quantasep 3000 SU System

March 2012: Sepragen signs Beacon Separations as manufacture representatives for mid west territory

July 2011: Genentech study shows 4 fold higher throughput with Superflo Radial Flow Chromatography Columns

April 2010: Quantasep 1000 SU, Single Use Flow-path System Launched

March 2010: Sepragen signs CB FINPRA as a distributor for its products in RUSSIA

February 2010: Sepragen announces the world’s first automated system for packing radial flow columns

January 2010: Sepragen signs Accuflow Solutions as manufacturer’s Representatives for Pennsylvania, New Jersey, Delaware and Maryland

December 2009: Sepragen signs AdaSci as manufacturer’s Representatives for Western Territory

December 2009: Sepragen signs Lab India as a distributor for its products in India

April 2009: Elan Study shows Sepragen bioreactor to be over 25 times more efficient than traditional Bag Bioreactor

March 2009: Sepragen signs Infors as a distributor for its products in the UK

May 17, 2006: Sepragen Announces Intent to Acquire Assets of Cytobiologics and Pursue Development of Integrated Cell Culture/Purification System


Click here to read all news and press releases prior to 2008.

Company | Products | News and Events | Contact Us | Terms and Conditions | Privacy Policy © 2020 Sepragen Corporation. All rights reserved. (510) 475-0650